PlainPharmaWatch

CMS Open Payments · Program Year 2024

GC Biopharma USA, Inc.

GC Biopharma USA, Inc. reported $8,133.61 in payments to 158 physicians and teaching hospitals across 158 transactions.

See the rankings → How this is sourced
$8.1K
Total payments
158
Transactions
158
Recipients
#1661
of 1,925 companies

GC Biopharma USA, Inc. reported $8,133.61 in payments to 158 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1661 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $51.48 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

GC Biopharma USA, Inc. pairs modest payment volume with a moderately concentrated payment pattern.

#1661
of 1,925 companies
0.0%
of all US industry payments
0.6%
paid to its single top recipient
1
payment categories

How GC Biopharma USA, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

GC Biopharma USA, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$8,134 14th percentile higher than 14% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). This entry sits in this band. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for GC Biopharma USA, Inc.

In Program Year 2024, GC Biopharma USA, Inc. reported $8,133.61 in payments to 158 physicians and teaching hospitals across 158 individual transactions, an average of $51.48 per transaction and $51.48 per recipient. That total places GC Biopharma USA, Inc. at rank #1661 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $8.1K (100.0% of the company's reported total, 158 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

GC Biopharma USA, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $8.1K, 100.0% of the company's reported total.

How GC Biopharma USA, Inc. divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$8.1K
Payment Type Amount Transactions
Food and Beverage $8.1K 158

Recipient Concentration in General Payments

The five largest recipient relationships account for $5,187.66 (63.8%) of $8,133.61 in this company's General Payments records across 141 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for GC Biopharma USA, Inc.

The five named recipients with the highest reported General Payments from this company

Raffi Tachdjian$5.0KTodd Hrabak$57.85Michael Polcari$45.22Duane Wong$42.78Ryan CASPER$41.81
  1. 1

    Raffi Tachdjian

    $5,000.00 across 1 reported transactions

  2. 2

    Todd Hrabak

    $57.85 across 3 reported transactions

  3. 3

    Michael Polcari

    $45.22 across 2 reported transactions

  4. 4

    Duane Wong

    $42.78 across 3 reported transactions

  5. 5

    Ryan CASPER

    $41.81 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $51.48. Average per recipient: $51.48.

Total Amount

$8,133.61

Avg per Transaction

$51.48

Avg per Recipient

$51.48

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

GC Biopharma USA, Inc. Share

0.0%

#1661 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to GC Biopharma USA, Inc.

Nipro Medical Corporation

$8.2K 3 recipients

NeuraSignal Inc.

$8.3K 11 recipients

OWP Pharmaceuticals, Inc.

$7.8K 412 recipients

Darco International, Inc.

$8.5K 6 recipients

Novo Nordisk US Research & Development, Inc.

$7.8K 3 recipients

Prolaio, Inc.

$8.5K 15 recipients

Frequently Asked Questions

How much did GC Biopharma USA, Inc. pay to physicians and hospitals in 2024? ▾
GC Biopharma USA, Inc. made $8,133.61 in payments to physicians and hospitals in Program Year 2024, across 158 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from GC Biopharma USA, Inc.? ▾
158 physicians and teaching hospitals received payments from GC Biopharma USA, Inc. in 2024, averaging $51.48 per recipient.
What types of payments did GC Biopharma USA, Inc. make? ▾
General payments from GC Biopharma USA, Inc. span 1 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $8.1K, representing 100.0% of the company's reported total.
How does GC Biopharma USA, Inc. rank among pharmaceutical companies? ▾
By total payment amount, GC Biopharma USA, Inc. sits at #1661 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from GC Biopharma USA, Inc.? ▾
GC Biopharma USA, Inc.'s 158 transactions to 158 recipients in 2024 averaged $51.48 per transaction.
Where does the payment data for GC Biopharma USA, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download GC Biopharma USA, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.